Q1 2023 Holdings
Filed 2023-05-15 | 106 holdings | $4.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medtech Acquisition Corp | UNIT 12/18/2025 | 58507N204 | $10 | 1 | 0.0% |
| Eucrates Biomedical Acqu COR | UNIT 10/23/2027 | G3141W114 | $10 | 1 | 0.0% |
| Eucrates Biomedical Acqu COR | *W EXP 10/23/202 | G3141W122 | $13.5K | 333,333 | 0.0% |
| Sientra Inc | COM | 82621J204 | $15.4K | 10,000 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $16.7K | 166,666 | 0.0% |
| Senior Connect Acquisitn COR | *W EXP 12/31/202 | 81723H116 | $19.6K | 500,000 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $20.0K | 166,666 | 0.0% |
| Medtech Acquisition Corp | *W EXP 12/22/202 | 58507N113 | $20.5K | 333,333 | 0.0% |
| Somalogic Inc | *W EXP 08/31/202 | 83444K113 | $36.0K | 120,000 | 0.0% |
| Quantum SI Inc | *W EXP 06/10/202 | 74765K113 | $50.0K | 333,333 | 0.0% |
| The Oncology Institute Inc(TOIIW) | *W EXP 11/15/202 | 68236X118 | $81.4K | 1,250,000 | 0.0% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $170.7K | 92,787 | 0.0% |
| Butterfly Network Inc(BFLYW) | *W EXP 02/12/202 | 124155110 | $195.1K | 733,333 | 0.0% |
| Medavail Holdings Inc | COM | 58406B103 | $239.8K | 836,626 | 0.0% |
| Caremax Inc | *W EXP 06/08/202 | 14171W111 | $323.8K | 672,000 | 0.0% |
| Roivant Sciences LTD | *W EXP 09/30/202 | G76279119 | $1.5M | 1,000,000 | 0.0% |
| Orchard Therapeutics PLC | SPON ADS NEW | 68570P200 | $1.7M | 316,169 | 0.0% |
| Rain Oncology Inc | COM | 75082Q105 | $2.0M | 227,393 | 0.0% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $2.0M | 2,651,667 | 0.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $2.2M | 583,913 | 0.1% |
| The Oncology Institute Inc(TOI) | COM | 68236X100 | $2.3M | 3,360,052 | 0.1% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $2.5M | 869,565 | 0.1% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $3.4M | 455,262 | 0.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $3.8M | 464,252 | 0.1% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $4.8M | 777,525 | 0.1% |
| Neogenomics Inc | NOTE 1.250% 5/0 | 64049MAA8 | $6.0M | $6,500,000 | 0.1% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $6.2M | 272,135 | 0.1% |
| Alector Inc(ALEC) | COM | 014442107 | $6.5M | 1,055,192 | 0.1% |
| Bluebird BIO Inc | COM | 09609G100 | $6.9M | 2,175,000 | 0.2% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $7.5M | 650,000 | 0.2% |
| Singular Genomics Systems in | COM | 82933R100 | $7.8M | 6,450,871 | 0.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $8.9M | 375,000 | 0.2% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $9.7M | 5,854,860 | 0.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $10.1M | 1,300,000 | 0.2% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $10.6M | 2,823,000 | 0.2% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $10.9M | 885,314 | 0.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $11.1M | 295,000 | 0.2% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $11.2M | 1,831,607 | 0.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $11.2M | 658,546 | 0.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $11.4M | 729,021 | 0.3% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $12.5M | 9,274,707 | 0.3% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $12.9M | 1,750,000 | 0.3% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $13.3M | 613,000 | 0.3% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $13.7M | 594,989 | 0.3% |
| Invitae Corp | NOTE 2.000% 9/0 | 46185LAB9 | $14.1M | $15,711,000 | 0.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $14.5M | 1,156,032 | 0.3% |
| OAK STR Health Inc | NOTE 3/1 | 67181AAB3 | $15.2M | $15,403,000 | 0.3% |
| Da32 Life Scnce TEC Acqstn C | CLASS A COM | 23312M106 | $16.2M | 1,600,000 | 0.4% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $16.3M | 1,046,791 | 0.4% |
| Xeris Biopharma Holdings Inc | NOTE 5.000% 7/1 | 98422LAA5 | $17.3M | $18,000,000 | 0.4% |